Boule Diagnostics AB
Research Boule Diagnostics AB (BOUL) on Bullrun: market cap SEK 126.21M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerBOUL
- ExchangeST
- CountrySweden
- SectorHealthcare
- IndustryMedical Devices
- CurrencySEK
- Market capSEK 126.21M
- Financial periodQ2 2026
- RevenueSEK 112.20M
- Net income-SEK 1.70M
- Free cash flow-SEK 3.50M
- Gross margin40.9%
Valuation Snapshot
latest market cap is SEK 126.21M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | SEK 489.70M | -SEK 3.50M | n/a | 43.7% | n/a | SEK 19.63M | SEK 223.76M | SEK 167.64M |
| FY2024 | SEK 558.46M | -SEK 296.58M | SEK 37.68M | 45.2% | n/a | SEK 22.65M | SEK 195.06M | SEK 196.37M |
| FY2023 | SEK 571.33M | SEK 24.98M | SEK 44.51M | 43.7% | 0.64 | SEK 37.28M | n/a | SEK 475.10M |
| FY2022 | SEK 548.09M | SEK 12.73M | -SEK 17.79M | 41.6% | 0.45 | SEK 96.90M | n/a | SEK 462.50M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-24 | SEK 126.21M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 SEK.
| Year | Dividends/share |
|---|---|
| FY2022 | 0.39 SEK |
About Boule Diagnostics AB
Boule Diagnostics AB (publ) develops, manufactures, and markets instruments and consumable products for blood diagnostics in the United States of America, Asia, Eastern Europe, Latin America, Western Europe, Africa, and the Middle East. It operates through Diagnostics and OEM Clinical Diagnostic Solutions. The company provides hematology analyzers, reagents, controls, and calibrators, under the Swelab, and Medonic brands;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Boule Diagnostics AB's market cap?
Boule Diagnostics AB's market capitalization is SEK 126.21M.
What does Boule Diagnostics AB do?
Boule Diagnostics AB (publ) develops, manufactures, and markets instruments and consumable products for blood diagnostics in the United States of America, Asia, Eastern Europe, Latin America, Western Europe, Africa, and the Middle East. It operates through Diagnostics and OEM Clinical Diagnostic Solutions. The company provides hematology analyzers, reagents, controls, and calibrators, under the Swelab, and Medonic brands; and veterinary hematology and clinical chemistry analyzer systems, as well as reagents and panels under the Exigo brand.